Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Breast cancer suppressor candidate 1 Antibody (OTI3D6), Biotin, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP271158B

Catalog No. NBP271158B


Only null left
Add to Cart

Description

Description

Breast cancer suppressor candidate 1 Monoclonal specifically detects Breast cancer suppressor candidate 1 in Human samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.
Specifications

Specifications

Breast cancer suppressor candidate 1
Monoclonal
Biotin
PBS with 0.05% Sodium Azide
VWA5A
Full length recombinant protein of human Breast cancer suppressor candidate 1 (NP_055437) produced in HEK293T cells.
0.1 mL
4013.0
Store at 4°C in the dark.
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence
OTI3D6
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence
BCSC-1Loss of heterozygosity 11 chromosomal region 2 gene A protein, BCSC1ortholog of mouse AW551984, Breast cancer suppressor candidate 1, LOH11CR2Avon Willebrand factor A domain-containing protein 5A, loss of heterozygosity, 11, chromosomal region 2, gene A, von Willebrand factor A domain containing 5A
Mouse
Affinity Purified
Primary
Human
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.